0.9411
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Pharmacyte Biotech Inc Azioni (PMCB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
|
8.50%
1.0419
|
0.9603 | 1.1061 | 1.2689 | 3.1662 |
Operating Income/Loss |
8.50%
-1.0419
|
-0.9603 | -1.1061 | -1.2689 | -3.1662 |
Nonoperating Income/Loss |
713.48%
12.79
|
-2.0851 | -0.3635 | 24.69 | 4.5129 |
Income/Loss From Continuing Operations Before Tax |
292.91%
11.75
|
-6.0907 | -1.4696 | 23.42 | 1.3467 |
Income/Loss From Continuing Operations After Tax |
292.91%
11.75
|
-6.0907 | -1.4696 | 23.42 | 1.3467 |
|
292.91%
11.75
|
-6.0907 | -1.4696 | 23.42 | 1.3467 |
Preferred Stock Dividends And Other Adjustments |
2.9708
|
- | - | - | 3.8872 |
Attributable To Noncontrolling Interest |
100.00%
-
|
-3.0453 | -2.9589 | - | - |
Basic Average Shares |
102.27%
-0.1582
|
6.96 | 7.637 | 7.8664 | -0.4103 |
Diluted Average Shares |
102.27%
-0.1582
|
6.96 | 7.637 | 7.8664 | -0.4103 |
Basic Earnings Per Share |
445.45%
1.52
|
-0.44 | -0.39 | 1.90 | -0.33 |
Diluted Earnings Per Share |
445.45%
1.52
|
-0.44 | -0.39 | 1.90 | -0.33 |
Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
736.85%
10.85
|
-1.7031 | -0.7388 | 14.96 | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
13.82
|
- | - | - | 3.8872 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):